FENC
Fennec Pharmaceuticals Inc

1,306
Loading...
Loading...
News
all
press releases
Is the Options Market Predicting a Spike in Adherex Technologies Stock?
Investors need to pay close attention to Adherex Technologies stock based on the movements in the options market lately.
Zacks·14d ago
News Placeholder
More News
News Placeholder
Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue Estimates
Adherex Technologies (FENC) delivered earnings and revenue surprises of -83.33% and +1.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of +5.88% and +2.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.77% and +47.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +21.74% and -71.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Concentra Group (CON) Matches Q2 Earnings Estimates
Concentra (CON) delivered earnings and revenue surprises of 0.00% and +2.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Are Medical Stocks Lagging Editas Medicine (EDIT) This Year?
Here is how Editas Medicine (EDIT) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's Why
Adherex Technologies (FENC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks·3mo ago
News Placeholder
The Joint Misses Q1 Earnings Estimates on Rising Expenses
Zacks·5mo ago
News Placeholder
Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions
Zacks·5mo ago

Latest FENC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.